serw-MX  [xml]  
 


    
 DeCS Categories

C14 Cardiovascular Diseases .
C14.240 Cardiovascular Abnormalities .
C14.240.400 Heart Defects, Congenital .
C14.240.400.280 Dextrocardia .
C14.280 Heart Diseases .
C14.280.400 Heart Defects, Congenital .
C14.280.400.280 Dextrocardia .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.240 Cardiovascular Abnormalities .
C16.131.240.400 Heart Defects, Congenital .
C16.131.240.400.280 Dextrocardia .
C16.131.810 Situs Inversus .
C16.131.810.250 Dextrocardia .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.202 Carbohydrate Metabolism, Inborn Errors .
C16.320.565.202.449 Glycogen Storage Disease .
C16.320.565.202.449.520 Glycogen Storage Disease Type III .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.202 Carbohydrate Metabolism, Inborn Errors .
C18.452.648.202.449 Glycogen Storage Disease .
C18.452.648.202.449.520 Glycogen Storage Disease Type III .
D02 Organic Chemicals .
D02.092 Amines .
D02.092.471 Ethylamines .
D02.092.471.683 Phenethylamines .
D02.092.471.683.152 Amphetamines .
D02.092.471.683.152.110 Amphetamine .
D02.092.471.683.152.110.200 Dextroamphetamine .
D02.691 Organometallic Compounds .
D02.691.550 Iron Compounds .
D02.691.550.100 Ferric Compounds .
D02.691.550.100.500 Iron-Dextran Complex .
D03 Heterocyclic Compounds .
D03.132 Alkaloids .
D03.132.577 Opiate Alkaloids .
D03.132.577.249 Morphinans .
D03.132.577.249.235 Dextrorphan .
D03.605 Heterocyclic Compounds, Bridged-Ring .
D03.605.497 Morphinans .
D03.605.497.260 Dextrorphan .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.400 Heterocyclic Compounds, 4 or More Rings .
D03.633.400.686 Morphinans .
D03.633.400.686.260 Dextrorphan .
D04 Polycyclic Compounds .
D04.615 Polycyclic Aromatic Hydrocarbons .
D04.615.723 Phenanthrenes .
D04.615.723.795 Morphinans .
D04.615.723.795.235 Dextrorphan .
D05 Macromolecular Substances .
D05.750 Polymers .
D05.750.078 Biopolymers .
D05.750.078.562 Glucans .
D05.750.078.562.272 Dextrans .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.277 Hydrolases .
D08.811.277.450 Glycoside Hydrolases .
D08.811.277.450.283 Dextranase .
D09 Carbohydrates .
D09.301 Dietary Carbohydrates .
D09.301.915 Starch .
D09.301.915.400 Dextrins .
D09.698 Polysaccharides .
D09.698.365 Glucans .
D09.698.365.272 Dextrans .
D09.698.365.272.400 Iron-Dextran Complex .
D09.698.365.855 Starch .
D09.698.365.855.400 Dextrins .
D09.947 Sugars .
D09.947.875 Monosaccharides .
D09.947.875.359 Hexoses .
D09.947.875.359.448 Glucose .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Dextrins .
1.00
 
Dextrans .
Dextran .
Dextran 40 .
Dextran 40000 .
Dextran 70 .
Dextran 75 .
Dextran 80 .
Dextran B-1355 .
Dextran B-1355-S .
Dextran B1355 .
Dextran B512 .
Dextran Derivatives .
Dextran M 70 .
Dextran T 70 .
Dextran T-40 .
Dextran T-500 .
Hemodex .
Hyskon .
Infukoll .
Macrodex .
Polyglucin .
Promit .
Rheodextran .
Rheoisodex .
Rheomacrodex .
Rheopolyglucin .
Rondex .
Saviosol .
Dextran B 1355 .
Dextran B 1355 S .
Dextran T 40 .
Dextran T 500 .
A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. .
0.83
 
Glucose .
Anhydrous Dextrose .
D-Glucose .
Glucose Monohydrate .
Glucose, (DL)-Isomer .
Glucose, (L)-Isomer .
Glucose, (alpha-D)-Isomer .
Glucose, (beta-D)-Isomer .
L-Glucose .
D Glucose .
Dextrose, Anhydrous .
L Glucose .
Monohydrate, Glucose .
Dextrose .
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. .
0.78
 
Dextranase .
Endo-Dextranase .
Glucanase 447-G .
Endo Dextranase .
Glucanase 447 G .
Enzyme that hydrolyzes DEXTRAN to OLIGOSACCHARIDES. .
0.74
 
Dextroamphetamine .
Curban .
Dexamfetamine .
Dexamphetamine .
Dexedrine .
Dextro-Amphetamine Sulfate .
DextroStat .
Dextroamphetamine Sulfate .
Oxydess .
d-Amphetamine Sulfate .
dextro-Amphetamine .
Dextro Amphetamine Sulfate .
Sulfate, Dextroamphetamine .
d Amphetamine .
d Amphetamine Sulfate .
dextro Amphetamine .
d-Amphetamine .
The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. .
0.73
 
Iron-Dextran Complex .
Dexferrum .
Dextrofer .
Feosol .
Ferridextran .
Hematran .
Icar 5759 .
Imfergen .
Imferon .
Imperon .
Imposil .
InFed .
Norferan .
Dextran Iron Complex .
Iron Dextran Complex .
Dextran-Iron Complex .
A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292) .
0.72
 
Dextrorphan .
(+-)-17-Methylmorphinan-3-ol .
Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN. .
0.67
 
Dextrocardia .
Dextrocardias .
A congenital defect in which the heart is located on the right side of the THORAX instead of on the left side (levocardia, the normal position). When dextrocardia is accompanied with inverted HEART ATRIA, a right-sided STOMACH, and a left-sided LIVER, the combination is called dextrocardia with SITUS INVERSUS. Dextrocardia may adversely affect other thoracic organs. .
0.67
 
Glycogen Storage Disease Type III .
Amylo-1,6-Glucosidase Deficiency .
Cori Disease .
Deficiency, Debrancher .
Glycogen Debrancher Deficiency .
Glycogen Storage Disease III .
Glycogen Storage Disease Type 3 .
Amylo 1,6 Glucosidase Deficiency .
Amylo-1,6-Glucosidase Deficiencies .
Coris Disease .
Debrancher Deficiencies .
Debrancher Deficiencies, Glycogen .
Debrancher Deficiency, Glycogen .
Deficiencies, Amylo-1,6-Glucosidase .
Deficiencies, Debrancher .
Deficiencies, Glycogen Debrancher .
Deficiency, Amylo-1,6-Glucosidase .
Deficiency, Glycogen Debrancher .
Dextrinoses, Limit .
Dextrinosis, Limit .
Disease, Cori .
Disease, Cori's .
Disease, Forbes .
Glycogen Debrancher Deficiencies .
Glycogenosis 3s .
Limit Dextrinoses .
Cori's Disease .
Debrancher Deficiency .
Forbes Disease .
Glycogen Debranching Enzyme Deficiency .
Glycogenosis 3 .
Limit Dextrinosis .
An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent. .
0.65